Back to Search
Start Over
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma.
- Source :
-
Hepatology (Baltimore, Md.) [Hepatology] 2019 Aug; Vol. 70 (2), pp. 745-747. Date of Electronic Publication: 2019 Apr 11. - Publication Year :
- 2019
- Subjects :
- Carcinoma, Hepatocellular pathology
Humans
Liver Neoplasms pathology
Male
Middle Aged
Treatment Outcome
Angiopoietin-2 antagonists & inhibitors
Carcinoma, Hepatocellular drug therapy
Liver Neoplasms drug therapy
Phenylurea Compounds pharmacology
Phenylurea Compounds therapeutic use
Pyridines pharmacology
Pyridines therapeutic use
Receptor, TIE-2 antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1527-3350
- Volume :
- 70
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Hepatology (Baltimore, Md.)
- Publication Type :
- Academic Journal
- Accession number :
- 30802985
- Full Text :
- https://doi.org/10.1002/hep.30588